NVSEF - Bausch Health sues Amneal Pharma over Xifaxan generic
2024-04-06 09:26:54 ET
More on Amneal, Bausch Health, etc.
- Amneal Pharmaceuticals, Inc. (AMRX) Q4 2023 Earnings Call Transcript
- Amneal Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Bausch Health: A Timely Divestiture Is The Key To An Higher Valuation
- Amneal Pharmaceuticals Q4 2023 Earnings Preview
- Amneal signs exclusive European licensing agreement with Zambon Biotech for IPX203